After the drug’s local license holder called for a brief pause in new patient starts last week, doctors in Japan can once again prescribe Amgen’s rare autoimmune disease med Tavneos (avacopan), albeit with revised safety precautions tucked into the product packaging.
Click here to view original post
Click Here to Publish/Feature Your Company or Product News with Biotech Networks
